SCHEMBL5250167

SCHEMBL5250167

O=C(O)N1CCC(CN2Cc3ccccc3C2=O)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 2/20 0.60
HTR2A P28223 1/20 0.60
TMEM97 Q5BJF2 1/20 0.60
KDM4E B2RXH2 2/20 0.53
ALOX15 P16050 2/20 0.53
TSHR P16473 2/20 0.53
SIRT1 Q96EB6 1/20 0.53
ACHE P22303 2/20 0.52
KEAP1 Q14145 3/20 0.49
NFE2L2 Q16236 3/20 0.49
PARP1 P09874 2/20 0.48
PREP P48147 2/20 0.47
DPP4 P27487 1/20 0.47
FAP Q12884 1/20 0.47
DPP8 Q6V1X1 1/20 0.47
DPP9 Q86TI2 1/20 0.47
GRM5 P41594 1/20 0.44
DRD2 P14416 1/20 0.43
DRD5 P21918 1/20 0.43
DRD3 P35462 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5249904 0.88 GRM5 (0.54) HTR1AHTR2ATMEM97KDM4EALOX15
SCHEMBL19028093 0.84 HTR1A (0.58) HTR1AHTR2ATMEM97KDM4EALOX15
SCHEMBL5250640 0.83 HTR1A (0.53) HTR1AHTR2ATMEM97KDM4EPARP1
SCHEMBL5242210 0.83 HTR1A (0.43) HTR1AHTR2ATMEM97ACHEKEAP1
SCHEMBL5251364 0.83 HTR1A (0.43) HTR1AHTR2ATMEM97KDM4EACHE
SCHEMBL2029501 0.83 HTR1A (0.43) HTR1AHTR2ATMEM97ACHEPARP1
SCHEMBL5243199 0.83 HTR1A (0.53) HTR1AHTR2ATMEM97PARP1GRM5
SCHEMBL6152303 0.82 HTR1A (0.53) HTR1AHTR2ATMEM97KDM4EACHE
SCHEMBL5250232 0.82 HTR1A (0.84) HTR1AHTR2ATMEM97KDM4EALOX15
Hydrochloric Acid SCHEMBL5250528 0.81 HTR1A (0.82) HTR1AHTR2ATMEM97KDM4EALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1260512-B1 NOVEL CYCLIC AMIDE DERIVATIVES MITSUBISHI PHARMA CORP (JP) 2007-07-04 EP disclosed
US-7166617-B2 Cyclic amide derivatives MITSUBISHI PHARMA CORPORATION (JP) 2007-01-23 US disclosed
US-20030212094-A1 Novel cyclic amide derivatives MITSUBISHI PHARMA CORPORATION (JP) 2003-11-13 US disclosed
EP-1260512-A1 NOVEL CYCLIC AMIDE DERIVATIVES Mitsubishi Pharma Corporation (JP) 2002-11-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212094-A1 Novel cyclic amide derivatives SIGMAR1, OPRM1, OPRD1 HTR1A 79/4885HTR2A 153/4885TMEM97 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.